Variant report
Variant | esv3429406 |
---|---|
Chromosome Location | chr16:76684151-76687849 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:76319924..76320753-chr16:76686923..76687617,2 | MCF-7 | breast: | |
2 | chr16:76687186..76688106-chr16:76857078..76857671,2 | MCF-7 | breast: | |
3 | chr16:75835108..75835786-chr16:76687075..76687822,2 | MCF-7 | breast: | |
4 | chr16:76679307..76681357-chr16:76683795..76685911,2 | MCF-7 | breast: | |
5 | chr16:75834944..75835823-chr16:76687371..76688062,3 | MCF-7 | breast: | |
6 | chr16:76687235..76688893-chr16:76692839..76694713,2 | K562 | blood: | |
7 | chr16:76312246..76313469-chr16:76687103..76688657,6 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs34113077 | chr16:76684422-76684423 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs547468150 | chr16:76684451-76684452 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs184382491 | chr16:76684497-76684498 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs371740229 | chr16:76684536-76684537 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532293591 | chr16:76684562-76684563 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs147992050 | chr16:76684584-76684585 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs568743695 | chr16:76684587-76684588 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs571570637 | chr16:76684636-76684637 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548310876 | chr16:76684641-76684642 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568052694 | chr16:76684652-76684653 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534053241 | chr16:76684678-76684679 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187685758 | chr16:76684681-76684682 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553492121 | chr16:76684708-76684709 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553365852 | chr16:76684710-76684711 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs191261873 | chr16:76684719-76684720 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549247091 | chr16:76684726-76684727 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs566045968 | chr16:76684747-76684748 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs540158392 | chr16:76684757-76684758 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs556873220 | chr16:76684768-76684769 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs535992303 | chr16:76684819-76684820 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs576743468 | chr16:76684826-76684827 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs141627689 | chr16:76684834-76684835 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs369292607 | chr16:76684846-76684847 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs562254578 | chr16:76684873-76684874 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs373181948 | chr16:76684888-76684889 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs572448598 | chr16:76684893-76684894 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs555570247 | chr16:76684913-76684914 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs150596234 | chr16:76684960-76684961 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs564347530 | chr16:76684980-76684981 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs557690860 | chr16:76684987-76684988 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184123505 | chr16:76685062-76685063 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188473967 | chr16:76685087-76685088 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562433855 | chr16:76685091-76685092 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs181615541 | chr16:76685109-76685110 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs548086405 | chr16:76685147-76685148 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs568206013 | chr16:76685150-76685151 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs185156317 | chr16:76685154-76685155 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs547440851 | chr16:76685182-76685183 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs138635211 | chr16:76685208-76685209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs539422978 | chr16:76685251-76685252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs575290852 | chr16:76685265-76685266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs140256395 | chr16:76685276-76685277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs76586486 | chr16:76685288-76685289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs7205389 | chr16:76685292-76685293 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs141761399 | chr16:76685328-76685329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs77219805 | chr16:76685397-76685398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs543471122 | chr16:76686601-76686602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs146088107 | chr16:76686634-76686635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs573950035 | chr16:76686683-76686684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs190014914 | chr16:76686690-76686691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 19156837 | CNVD |
Acute myeloid leukemia | 17377590 | CNVD |
Breast cancer | 20409316 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Lung cancer | 24585490 | CNVD |
Cancer | 20164919 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Cancer | 20164920 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:76684400-76685200 | Flanking Active TSS | A549 | lung |
2 | chr16:76684600-76685200 | Enhancers | HepG2 | liver |
3 | chr16:76685200-76685400 | Enhancers | A549 | lung |
4 | chr16:76686600-76687000 | Enhancers | Fetal Brain Male | brain |
5 | chr16:76687200-76687800 | Enhancers | Brain Inferior Temporal Lobe | brain |
6 | chr16:76687200-76688000 | Enhancers | Brain Substantia Nigra | brain |
7 | chr16:76687200-76688200 | Enhancers | Fetal Lung | lung |
8 | chr16:76687600-76688200 | Enhancers | Brain Hippocampus Middle | brain |
9 | chr16:76687600-76689600 | Enhancers | Brain Germinal Matrix | brain |